In experimental atherosclerosis, it has been proved that the selective neutralization of IL-1β promotes monocytes to switch to a less inflammatory state in plasma, elicits higher plasma level of IL-10, and lessens atherosclerosis plaque size without limitation of compensatory outward remodeling in the artery (44). The gene discussed is IL1B; the disease is atherosclerosis.